| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2015 ( Subtotal = -$1,173,087 ) |
| | 2015 | 2014 | TRANSPOSAGEN BIOPHARMACEUTICALS INC | 3701 Market St FL 4 | Philadelphia | PA | 19104-5502 | PHILADELPHIA | USA | R43ES023718 | Novel reporter cell lines for neurotoxicant assays | 000 | 1 | NIH | 3/24/2015 | -$225,000 |
| | 2015 | 2014 | TRANSPOSAGEN BIOPHARMACEUTICALS INC | 3701 Market St FL 4 | Philadelphia | PA | 19104-5502 | PHILADELPHIA | USA | R44GM099206 | Novel method to create knockout rats using endonucleases and spermatogonial stem | 001 | 2 | NIH | 4/3/2015 | -$687,732 |
| | 2015 | 2014 | TRANSPOSAGEN BIOPHARMACEUTICALS INC | 3701 Market St FL 4 | Philadelphia | PA | 19104-5502 | PHILADELPHIA | USA | R44GM099206 | Novel method to create knockout rats using endonucleases and spermatogonial stem | 000 | 2 | NIH | 11/20/2014 | -$260,355 |
|
| Issue Date FY: 2014 ( Subtotal = $1,173,087 ) |
| | 2014 | 2014 | TRANSPOSAGEN BIOPHARMACEUTICALS INC | 3701 Market St FL 4 | Philadelphia | PA | 19104-5502 | PHILADELPHIA | USA | R43ES023718 | Novel reporter cell lines for neurotoxicant assays | 000 | 1 | NIH | 9/18/2014 | $225,000 |
| | 2014 | 2014 | TRANSPOSAGEN BIOPHARMACEUTICALS INC | 3701 Market St FL 4 | Philadelphia | PA | 19104-5502 | PHILADELPHIA | USA | R44GM099206 | Novel method to create knockout rats using endonucleases and spermatogonial stem | 000 | 2 | NIH | 9/24/2014 | $948,087 |
|
| Issue Date FY: 2013 ( Subtotal = $32,223 ) |
| | 2013 | 2011 | TRANSPOSAGEN BIOPHARMACEUTICALS INC | 3701 Market St FL 4 | Philadelphia | PA | 19104-5502 | PHILADELPHIA | USA | R44RR025738 | CREATION OF HYPERACTIVE TRANSPOSONS FOR MUTAGENESIS IN RODENTS | 000 | 3 | NIH | 3/21/2013 | $32,223 |
|
| Issue Date FY: 2011 ( Subtotal = $1,312,145 ) |
| | 2011 | 2011 | TRANSPOSAGEN BIOPHARMACEUTICALS INC | 3701 Market St FL 4 | Philadelphia | PA | 19104-5502 | PHILADELPHIA | USA | R44RR025738 | CREATION OF HYPERACTIVE TRANSPOSONS FOR MUTAGENESIS IN RODENTS | 001 | 3 | NIH | 9/17/2011 | $867,642 |
| | 2011 | 2011 | TRANSPOSAGEN BIOPHARMACEUTICALS INC | 3701 Market St FL 4 | Philadelphia | PA | 19104-5502 | PHILADELPHIA | USA | R43HG005799 | GENERATION OF SITE-SPECIFIC RECOMBINASE-EXPRESSING TRANSGENIC RATS USING AN ENHAN | 001 | 2 | NIH | 9/16/2011 | $42,001 |
| | 2011 | 2011 | TRANSPOSAGEN BIOPHARMACEUTICALS INC | 3701 Market St FL 4 | Philadelphia | PA | 19104-5502 | PHILADELPHIA | USA | R43HG005799 | GENERATION OF SITE-SPECIFIC RECOMBINASE-EXPRESSING TRANSGENIC RATS USING AN ENHAN | 000 | 2 | NIH | 9/15/2011 | $60,456 |
| | 2011 | 2011 | TRANSPOSAGEN BIOPHARMACEUTICALS INC | 3701 Market St FL 4 | Philadelphia | PA | 19104-5502 | PHILADELPHIA | USA | R43GM099206 | NOVEL METHOD TO CREATE KNOCKOUT RATS USING ENDONUCLEASES AND SPERMATAGONIALSTEM | 000 | 1 | NIH | 9/5/2011 | $342,046 |
| | 2011 | 2010 | TRANSPOSAGEN BIOPHARMACEUTICALS INC | 3160 CHESTNUT STREET | PHILADELPHIA | PA | 19104 | PHILADELPHIA | USA | R44RR025738 | CREATION OF HYPERACTIVE TRANSPOSONS FOR MUTAGENESIS IN RODENTS | 000 | 2 | NIH | 9/1/2011 | $0 |
|
| Issue Date FY: 2010 ( Subtotal = $1,275,903 ) |
| | 2010 | 2010 | TRANSPOSAGEN BIOPHARMACEUTICALS INC | 3701 Market St FL 4 | Philadelphia | PA | 19104-5502 | PHILADELPHIA | USA | R43CA138336 | TISSUE-SPECIFIC MUTAGENESIS IN RAT AS AN IN VIVO TOOL FOR COLON CANCER GENE DISCO | 001 | 2 | NIH | 6/21/2010 | $141,068 |
| | 2010 | 2010 | TRANSPOSAGEN BIOPHARMACEUTICALS INC | 3701 Market St FL 4 | Philadelphia | PA | 19104-5502 | PHILADELPHIA | USA | R43HG005799 | GENERATION OF SITE-SPECIFIC RECOMBINASE-EXPRESSING TRANSGENIC RATS USING AN ENHAN | 000 | 1 | NIH | 9/8/2010 | $180,181 |
| | 2010 | 2010 | TRANSPOSAGEN BIOPHARMACEUTICALS INC | 3160 CHESTNUT STREET | PHILADELPHIA | PA | 19104 | PHILADELPHIA | USA | R43HG005799 | GENERATION OF SITE-SPECIFIC RECOMBINASE-EXPRESSING TRANSGENIC RATS USING AN ENHAN | 001 | 1 | NIH | 9/29/2010 | $0 |
| | 2010 | 2010 | TRANSPOSAGEN BIOPHARMACEUTICALS INC | 3701 Market St FL 4 | Philadelphia | PA | 19104-5502 | PHILADELPHIA | USA | R43GM093748 | NOVEL SCID RAT MODELS FOR HUMAN CELL TRANSPLANTATION STUDIES | 000 | 1 | NIH | 6/25/2010 | $174,707 |
| | 2010 | 2010 | TRANSPOSAGEN BIOPHARMACEUTICALS INC | 3701 Market St FL 4 | Philadelphia | PA | 19104-5502 | PHILADELPHIA | USA | R44RR025738 | CREATION OF HYPERACTIVE TRANSPOSONS FOR MUTAGENESIS IN RODENTS | 000 | 2 | NIH | 8/20/2010 | $779,947 |
| | 2010 | 2009 | TRANSPOSAGEN BIOPHARMACEUTICALS INC | 3160 CHESTNUT STREET | PHILADELPHIA | PA | 19104 | PHILADELPHIA | USA | R43CA138336 | TISSUE-SPECIFIC MUTAGENESIS IN RAT AS AN IN VIVO TOOL FOR COLON CANCER GENE DISCO | 000 | 1 | NIH | 11/4/2009 | $0 |
| | 2010 | 2009 | TRANSPOSAGEN BIOPHARMACEUTICALS INC | 3160 CHESTNUT STREET | PHILADELPHIA | PA | 19104 | PHILADELPHIA | USA | R43RR025738 | CREATION OF HYPERACTIVE TRANSPOSONS FOR MUTAGENESIS IN RODENTS | 000 | 1 | NIH | 8/18/2010 | $0 |
|
| Issue Date FY: 2009 ( Subtotal = $675,011 ) |
| | 2009 | 2009 | TRANSPOSAGEN BIOPHARMACEUTICALS INC | 3701 Market St FL 4 | Philadelphia | PA | 19104-5502 | PHILADELPHIA | USA | R43CA138336 | TISSUE-SPECIFIC MUTAGENESIS IN RAT AS AN IN VIVO TOOL FOR COLON CANCER GENE DISCO | 000 | 1 | NIH | 5/1/2009 | $171,560 |
| | 2009 | 2009 | TRANSPOSAGEN BIOPHARMACEUTICALS INC | 3701 Market St FL 4 | Philadelphia | PA | 19104-5502 | PHILADELPHIA | USA | R43RR025738 | CREATION OF HYPERACTIVE TRANSPOSONS FOR MUTAGENESIS IN RODENTS | 000 | 1 | NIH | 2/23/2009 | $295,614 |
| | 2009 | 2009 | TRANSPOSAGEN BIOPHARMACEUTICALS INC | 3701 Market St FL 4 | Philadelphia | PA | 19104-5502 | PHILADELPHIA | USA | R44RR021289 | L1 RETROTRANSPOSON-BASED MUTAGENESIS FOR RAT MODELS OF HUMAN DISEASES | 003 | 3 | NIH | 1/12/2009 | $189,865 |
| | 2009 | 2008 | TRANSPOSAGEN BIOPHARMACEUTICALS INC | 3160 CHESTNUT STREET | PHILADELPHIA | PA | 19104 | PHILADELPHIA | USA | R44RR021289 | L1 RETROTRANSPOSON-BASED MUTAGENESIS FOR RAT MODELS OF HUMAN DISEASES | 002 | 3 | NIH | 12/15/2008 | $0 |
| | 2009 | 2008 | TRANSPOSAGEN BIOPHARMACEUTICALS INC | 3160 CHESTNUT STREET | PHILADELPHIA | PA | 19104 | PHILADELPHIA | USA | R44RR021289 | L1 RETROTRANSPOSON-BASED MUTAGENESIS FOR RAT MODELS OF HUMAN DISEASES | 001 | 3 | NIH | 11/3/2008 | $0 |
| | 2009 | 2008 | TRANSPOSAGEN BIOPHARMACEUTICALS INC | 3701 Market St FL 4 | Philadelphia | PA | 19104-5502 | PHILADELPHIA | USA | F32CA126294 | IDENTIFICATION OF COLON CANCER GENES VIA RETROTRANSPOSON MUTAGENESIS | 000 | 4 | NIH | 7/21/2009 | -$19,505 |
| | 2009 | 2007 | TRANSPOSAGEN BIOPHARMACEUTICALS INC | 3701 Market St FL 4 | Philadelphia | PA | 19104-5502 | PHILADELPHIA | USA | R44RR021289 | L1 RETROTRANSPOSON-BASED MUTAGENESIS FOR RAT MODELS OF HUMAN DISEASES | 000 | 2 | NIH | 12/10/2008 | $37,477 |
|
| Issue Date FY: 2008 ( Subtotal = $718,748 ) |
| | 2008 | 2008 | TRANSPOSAGEN BIOPHARMACEUTICALS INC | 3160 CHESTNUT STREET | PHILADELPHIA | PA | 19104 | PHILADELPHIA | USA | R44RR021289 | L1 RETROTRANSPOSON-BASED MUTAGENESIS FOR RAT MODELS OF HUMAN DISEASES | 000 | 3 | NIH | 9/12/2008 | $668,320 |
| | 2008 | 2008 | TRANSPOSAGEN BIOPHARMACEUTICALS INC | 3160 CHESTNUT STREET | PHILADELPHIA | PA | 19104 | PHILADELPHIA | USA | F32CA126294 | IDENTIFICATION OF COLON CANCER GENES VIA RETROTRANSPOSON MUTAGENESIS | 000 | 4 | NIH | 9/10/2008 | $50,428 |
|
| Issue Date FY: 2007 ( Subtotal = $650,666 ) |
| | 2007 | 2007 | TRANSPOSAGEN BIOPHARMACEUTICALS INC | 3160 CHESTNUT STREET | PHILADELPHIA | PA | 19104 | PHILADELPHIA | USA | R44RR021289 | L1 RETROTRANSPOSON-BASED MUTAGENESIS FOR RAT MODELS OF HUMAN DISEASES | 000 | 2 | NIH | 5/22/2007 | $650,666 |
|
| Issue Date FY: 2005 ( Subtotal = $99,724 ) |
| | 2005 | 2005 | TRANSPOSAGEN BIOPHARMACEUTICALS INC | 3160 CHESTNUT STREET | PHILADELPHIA | PA | 19104 | PHILADELPHIA | USA | R43RR021289 | L1 MUTAGENESIS FOR MAMMALIAN MODELS OF HUMAN DISEASES | 000 | 1 | NIH | 2/11/2005 | $99,724 |
|
|
